News

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...
Wellness influencer Janelle Rohner is receiving backlash after admitting to, and then apologizing for, using a weight loss ...
GLP-1 receptor agonists are effective weight-loss medications, but they may also decrease muscle mass, raising concerns about ...
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
Trending weight loss drugs such as Ozempic and Wegovy may be highly effective at tackling obesity, but are they also carrying ...
Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.
The weekly shot that's transforming weight loss journeys. Discover how Zepbound is reshaping obesity treatment and offering ...
Defensive lineman Desmond Watson shed 26 pounds in less than a month, but if selected in the NFL draft would still be ...
Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...
The South Korean office of the Danish pharmaceutical company Novo Nordisk recently requested the local authorities to permit ...